Gerard MOINET

Treatment for the non alcoholic steatohepatitis and fibrosis

Composition and kit comprising piperazine derivatives and metformin, and use thereof in the treatment of diabetes

Substituted pyrrolo[1,2-A]pyrazin-1-ones and pyrazolo[1,5-A]pyrazin-4-ones as inhibitors of tankyrase and poly(ADP-ribose)polymerase activity

Piperazine derivatives, methods for preparing same, and uses thereof in the treatment of insulin resistance

Piperazine derivatives, methods for preparing same, and uses thereof in the treatment of insulin resistance

COMBINATION OF TRIAZINE DERIVATIVES AND INSULIN SENSITISERS

Combination of triazine derivatives and insulin sensitisers

Combination of triazine derivatives and insulin secretion stimulators

Use of triazine derivatives for the manufacture of a medicament having a cicatrising or angiogenic effect

COMBINATION OF TRIAZINE DERIVATIVES AND PPARalpha AGONISTS

COMBINATION OF TRIAZINE DERIVATIVES AND HMG-COA REDUCTASE INHIBITORS

Use of AMPK-activating imidazole derivatives, preparation process therefor and pharmaceutical compositions comprising them

Bicyclic guanidine derivatives and therapeutic uses thereof

Imidazole derivatives as fructose-1,6-bisphosphatase inhibitors and pharmaceutical compositions containing them

Imidazolecarboxamide derivatives as fructose-1,6-bisphosphatase inhibitors, and pharmaceutical compositions comprising same

Dihydro-1,3,5-triazine amine derivatives and their therapeutic uses

Dihydro-1,3,5-triazine amine derivatives and their therapeutic uses

Phenylcarboxylic acid derivatives and use thereof for the treatment of diabetes

Biguanide derivatives

Acidic quinoline derivatives and their use for the prevention and/or treatment of hyperglycaemia-related pathologies

Antidiabetic compounds comprising benzofuran and benzothiophene derivatives

Benzofurans and benzothiophenes

Process for resolving aimines that are useful for the treatment of disorders associated with insulin resistance syndrome

Kynurenine 3-hydroxylase inhibitors for the treatment of diabetes

Dihydro-1,3,5-triazine amine derivatives and their therapeutic uses

Kynurenine 3-hydroxylase inhibitors for the treatment of diabetes by increasing the number of islets of langerhans cells

Dihydro-1,3,5-triazine amine derivatives and their therapeutic uses

Pharmaceutical composition comprising a glitazone and a 4-oxobutanoic acid, and the use thereof for treating diabetes

Pharmaceutical composition comprising an alpha-glucosidase inhibitor and a 4-oxobutanoic acid, and the use thereof for treating diabetes

Use of 4-oxobutanoic acid derivatives in the treatment of inflammation